AI assistant
ABBOTT LABORATORIES — Director's Dealing 2015
Feb 24, 2015
29777_rns_2015-02-24_9964784d-7967-4410-a85b-952e3c654367.pdf
Director's Dealing
Open in viewerOpens in your device viewer
SEC FORM 4 Page 1 of 1
SEC Form 4
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| OMB APPROVAL | ||
|---|---|---|
| OMB Number: | 3235-0287 | |
| Expires: | December 31, 2014 | |
| Estimated average burden hours per response: | 0.5 | |
| 1. Name and Address of Reporting Person | ||
| Warmuth Michael J | ||
| ABBOTT LABORATORIES [ ABT ] | ||
| (Check all applicable) | ||
| Director 10% Owner | ||
| X Officer (give title below) | ||
| Other (specify below) | ||
| Executive Vice President | ||
| --- | --- | --- |
| (Last) (First) (Middle) | ||
| 100 ABBOTT PARK ROAD | ||
| 02/20/2015 | ||
| (Street) | ||
| ABBOTT PARK IL 60064-6400 | ||
| X Form filed by One Reporting Person | ||
| Form filed by More than One Reporting Person | ||
| (City) (State) (Zip) | ||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||
| 1. Title of Security (Instr. 3) | 2. Transaction Date | |
| (Month/Day/Year) | 2A. Deemed Execution Date, if any | |
| (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) |
| Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | |
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||
| (e.g., puts, calls, warrants, options, convertible securities) | ||
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date |
| (Month/Day/Year) | 3A. Deemed Execution Date, if any | |
| (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
| (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | |
| Following Reported Transaction(s) (Instr. 4) | ||
| Option (right to buy) (1) | $47 | 02/20/2015 |
Explanation of Responses:
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 60,345 on 2/20/16, 60,344 on 2/20/17, and 60,345 on 2/20/18.
John A. Berry, by power of attorney for Michael J. Warmuth 02/24/2015
Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
http://www.sec.gov/Archives/edgar/data/1800/000117911015003332/xslF345X03/edgar.xml 2/24/2015